Evidence of a functional estrogen receptor in parathyroid adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4631-4639

  Haglund, Felix ^a   Ma, Ran ^a   Huss, Mikael ^a   Sulaiman, Luqman ^a   Lu, Ming ^a   Nilsson, Inga Lena ^a   Höög, Anders ^a   Juhlin, C Christofer ^a   Hartman, Johan ^a   Larsson, Catharina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AFIMOXIFENE; DIARYLPROPIONITRILE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA 1; ESTROGEN RECEPTOR BETA 2; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; CALR GENE; CASR GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; ESR1 GENE; ESR2 GENE; FEMALE; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUN GENE; MALE; METHYLATION; NUCLEOTIDE SEQUENCE; ORAI2 GENE; PARATHYROID ADENOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEX DIFFERENCE; TUMOR CELL; TUMOR CELL CULTURE; TUMOR VOLUME; VDR GENE;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PARATHYROID NEOPLASMS; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN; TRANSCRIPTOME;

EID: 84870764389     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2484     Document Type: Article

References (39)

1. Lundgren E, Hagström EG, Lundin J, Winnerbäck K, Roos J, Ljunghall S, Rastad J 2002 Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World J Surg 26:931-936 (Pubitemid 36920289)
2. DeLellis RA, Mazzaglia P, Mangray S 2008 Primary hyperparathyroidism-a current perspective. Arch Pathol Lab Med 132:1251-1262
3. Taniegra ED 2004 Hyperparathyroidism. Am Fam Physician 69:333-339
4. Hagström E, Lundgren E, Lithell H, Berglund L, Ljunghall S, Hellman P, Rastad J 2002 Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol (Oxf) 56:253-260 (Pubitemid 34233964)
5. Greenberg C, Kukreja SC, Bowser EN, Hargis GK, Henderson WJ, Williams GA 1987 Parathyroid hormone secretion: effect of estradiol and progesterone. Metabolism 36:151-154 (Pubitemid 17024109)
6. Wong C, Lai T, Hilly JM, Stewart CE, Farndon JR 2002 Selective estrogen receptor modulators inhibit the effects of insulin-like growth factors in hyperparathyroidism. Surgery 132:998-1006; discussion 1006-1007; discussion 1006-1007
7. Rubin MR, Lee KH, McMahon DJ, Silverberg SJ 2003 Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 88:1174-1178 (Pubitemid 36337773)
8. Diamond T, Ng AT, Levy S, Magarey C, Smart R 1996 Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report. Osteoporos Int 6:329-333
9. Farford B, Presutti RJ, Moraghan TJ 2007 Nonsurgical management of primary hyperparathyroidism. Mayo Clin Proc 82:351-355 (Pubitemid 46348936)
10. Nilsson S, Koehler KF, Gustafsson JÅ 2011 Development of subtype-selective oestrogen receptor-based therapeutics. Nat Rev Drug Discov 10:778-792
11. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930 (Pubitemid 26190778)
12. Petersen DN, Tkalcevic GT, Koza-Taylor PH, Turi TG, Brown TA 1998 Identification of estrogen receptor β2, a functional variant of estrogen receptor β expressed in normal rat tissues. Endocrinology 139:1082-1092 (Pubitemid 28510126)
13. Maruyama K, Endoh H, Sasaki-Iwaoka H, Kanou H, Shimaya E, Hashimoto S, Kato S, Kawashima H 1998 A novel isoform of rat estrogen receptor β with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action. Biochem Biophys Res Commun 246:142-147 (Pubitemid 28413942)
14. Hammes SR, Levin ER 2007 Extranuclear steroid receptors: nature and actions. Endocr Rev 28:726-741 (Pubitemid 350294293)
15. Helguero LA, Faulds MH, Gustafsson JA, Haldosén LA 2005 Estrogen receptors α (ERα) and β (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24:6605-6616 (Pubitemid 41486791)
16. Hartman J, Ström A, Gustafsson JA 2009 Estrogen receptor β in breast cancer-diagnostic and therapeutic implications. Steroids 74:635-641
17. Safe S, Kim K, Kim K 2008 Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol 41:263-275
18. Hirano S, Furutama D, Hanafusa T 2007 Physiologically high concentrations of 17β-estradiol enhance NF-κB activity in human T cells. Am J Physiol Regul Integr Comp Physiol 292:R1465-R1471 (Pubitemid 46557806)
19. Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson JA, Safe S 2000 Ligand-, cell-, and estrogen receptor subtype (α/β)- dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 275:5379-5387 (Pubitemid 30115168)
20. Wade CB, Dorsa DM 2003 Estrogen activation of cyclic adenosine 5′-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway. Endocrinology 144:832-838 (Pubitemid 36262850)
21. Haglund F, Lu M, Vukojeviæ V, Nilsson IL, Andreasson A, DžabiæM, Bränström R, Höög A, Juhlin CC, Larsson C 2012 Prolactin receptor in primary hyperparathyroidism-expression, functionality and clinical correlations. PLoS One 7:e36448
22. Lu M, Berglund E, Larsson C, Höög A, Farnebo LO, Bränström R 2011 Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma. J Endocrinol 208:31-39
23. Hartman J, Lindberg K, Morani A, Inzunza J, Ström A, Gustafsson JA 2006 Estrogen receptor β inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 66:11207-11213 (Pubitemid 46009948)
24. Juhlin CC, Kiss NB, Villablanca A, Haglund F, Nordenström J, Höög A, Larsson C 2010 Frequent promoter hypermethylation of the APC and RASSF1 A tumour suppressors in parathyroid tumours. PLoS One 5:e9472
25. Stranneheim H, Werne B, Sherwood E, Lundeberg J 2011 Scalable transcriptome preparation for massive parallel sequencing. PLoS One 6:e21910
26. Robinson MD, McCarthy DJ, Smyth GK 2010 edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139-140
27. Kupershmidt I, Su QJ, Grewal A, Sundaresh S, Halperin I, Flynn J, Shekar M, Wang H, Park J, Cui W, Wall GD, Wisotzkey R, Alag S, Akhtari S, Ronaghi M 2010 Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One 5:pii:e13066
28. Grober OM, Mutarelli M, Giurato G, Ravo M, Cicatiello L, De Filippo MR, Ferraro L, Nassa G, Papa MF, Paris O, Tarallo R, Luo S, Schroth GP, Benes V, Weisz A 2011 Global analysis of estrogen receptor β binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor α for target gene regulation. BMC Genomics 12:36
29. Prince RL, MacLaughlin DT, Gaz RD, Neer RM 1991 Lack of evidence for estrogen receptors in human and bovine parathyroid tissue. J Clin Endocrinol Metab 72:1226-1228 (Pubitemid 21921832)
30. Wang M, Pan JY, Song GR, Chen HB, An LJ, Qu SX 2007 Altered expression of estrogen receptor α and β in advanced gastric adenocarcinoma: correlation with prothymosin α and clinicopathological parameters. Eur J Surg Oncol 33:195-201 (Pubitemid 46336548)
31. Corbetta S, Vicentini L, Ferrero S, Lania A, Mantovani G, Cordella D, Beck-Peccoz P, Spada A 2005 Activity and function of the nuclear factor κB pathway in human parathyroid tumors. Endocr Relat Cancer 12:929-937 (Pubitemid 41815786)
32. Kishikawa S, Shan L, Ogihara K, Utsunomiya H, Nakamura M, Nakamura Y, Naito A, Kakudo K 1999 Overexpression and genetic abnormality of p53 in parathyroid adenomas. Pathol Int 49:853-857
33. Thakker RV 1998 Disorders of the calcium-sensing receptor. Biochim Biophys Acta 1448:166-170 (Pubitemid 29052189)
34. Okazaki T, Igarashi T, Kronenberg HM 1988 5′-Flanking region of the parathyroid hormone gene mediates negative regulation by 1,25-(OH)2 vitamin D3. J Biol Chem 263:2203-2208 (Pubitemid 18060274)
35. Sela-Brown A, Russell J, Koszewski NJ, Michalak M, Naveh-Many T, Silver J 1998 Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats. Mol Endocrinol 12:1193-1200
36. DeHaven WI, Smyth JT, Boyles RR, Putney Jr JW 2007 Calcium inhibition and calcium potentiation of Orai1, Orai2, and Orai3 calcium release-activated calcium channels. J Biol Chem 282:17548-17556 (Pubitemid 47100303)
37. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Ström A, Treuter E, Warner M, Gustafsson JA 2007 Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87:905-931 (Pubitemid 47084672)
38. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, Melton 3rd LJ 2006 Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res 21:171-177 (Pubitemid 43023239)
39. Burger HG, MacLennan AH, Huang KE, Castelo-Branco C 2012 Evidence-based assessment of the impact of the WHI on women's health. Climacteric 15:281-287